Shockwave Medical Inc (SWAV)
330.34
+0.34
(+0.10%)
USD |
NASDAQ |
May 03, 16:00
330.38
+0.04
(+0.01%)
After-Hours: 19:10
Shockwave Medical Cash from Financing (Quarterly): -0.164M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.164M |
September 30, 2023 | 613.00M |
June 30, 2023 | -95.84M |
March 31, 2023 | 83.41M |
December 31, 2022 | 9.596M |
September 30, 2022 | 0.383M |
June 30, 2022 | 0.50M |
March 31, 2022 | 2.52M |
December 31, 2021 | 0.50M |
September 30, 2021 | 2.387M |
June 30, 2021 | -2.138M |
March 31, 2021 | -3.20M |
Date | Value |
---|---|
December 31, 2020 | 1.173M |
September 30, 2020 | 1.284M |
June 30, 2020 | 83.65M |
March 31, 2020 | 3.93M |
December 31, 2019 | 96.37M |
September 30, 2019 | 0.491M |
June 30, 2019 | -2.067M |
March 31, 2019 | 113.26M |
December 31, 2018 | 19.32M |
September 30, 2018 | 0.025M |
June 30, 2018 | 10.05M |
March 31, 2018 | 0.416M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-95.84M
Minimum
Jun 2023
613.00M
Maximum
Sep 2023
41.88M
Average
1.173M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
Boston Scientific Corp | 1.569B |
AtriCure Inc | -7.862M |
Masimo Corp | -36.30M |
Perspective Therapeutics Inc | 0.352M |
Xtant Medical Holdings Inc | 0.325M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 71.70M |
Cash from Investing (Quarterly) | -242.26M |
Free Cash Flow | 165.46M |
Free Cash Flow Per Share (Quarterly) | 1.661 |
Free Cash Flow to Equity (Quarterly) | 62.64M |
Free Cash Flow to Firm (Quarterly) | 65.94M |
Free Cash Flow Yield | 1.31% |